Viadeo
Media & Internet · France · 201-500 Employees
View Company Info for Free
Overview
Headquarters
30 Rue De La Victoire, Paris, Ile-de-Fra...Phone Number
+33 175443124Website
www.viadeo.comRevenue
$21 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Viadeo
Viadeo is a professional networking platform that focuses on connecting decision-makers across various industries including retail, media, fintech, IoT, and smart cities. The company offers services related to big data, cloud computing, SEO, and e-health, catering to a diverse clientele that includes publishers and management professionals. Viadeo aims to facilitate networking and collaboration among professionals, enhancing their business opportunities. The platform also supports sectors like adtech, foodtech, and martech, making it a versatile tool for modern professionals.Explore more
Viadeo Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viadeo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Viadeo
Click to see if Viadeo had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Viadeo, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Viadeo recently announced quarterly report
Funding: Get notified immidiatlly once Viadeo has new funding data
Product Launch: Get notified when Viadeo launches new products
Check if Viadeo has recently received funding, and reach out quickly before it becomes old news!
Check out if Viadeo is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Viadeo as Masked Content
Find 2 more new buyers
Products Owned by Viadeo
Viadeo Widgets
Company Profile Activity
Activity Insights
Viadeo is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Viadeo is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Viadeo.
Viadeo Tech Stack
A closer look at the technologies used by Viadeo
See more technologies
Viadeo News & Media
Aptevo Therapeutics and MorphoSys End Joint Development and Commercialization Agreement for MOR209/ES414
Aptevo Regains Worldwide Rights to Novel Bispecific Prostate Cancer Immunotherapeutic MOR209/ES414 Preliminary Phase I Data Show Markedly Lower Anti-Drug Antibody Titers Demonstrating Effectiveness of New Dosing Regimen SEATTLE, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, today announced the end of its partnership with MorphoSys AG for the joint worldwide development andAptevo Therapeutics and Alligator Bioscience Commence IND-Enabling Development Activities for New Bispecific Immunotherapy Candidate ALG.APV-527
Novel Bispecific Antibody Targeting Biological Pathway Implicated in Multiple Solid Tumor Indications SEATTLE and LUND, Sweden, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm:ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the companies have initiatedAptevo Therapeutics and Alligator Bioscience Commence IND-Enabling Development Activities for New Bispecific Immunotherapy Candidate ALG.APV-527
Novel Bispecific Antibody Targeting Biological Pathway Implicated in Multiple Solid Tumor Indications SEATTLE and LUND, Sweden, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm:ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the companies have initiatedAptevo Therapeutics Reports Second Quarter 2017 Financial Results
Showcases Differentiating Features of the ADAPTIR™ Protein Therapeutic Platform at Prominent Industry Conferences Signs Collaboration Agreement with Alligator Bioscience Expanding Aptevo’s Portfolio to Include a New Bispecific Antibody Candidate with a Novel Mechanism of Action Targeting 4-1BB, a Compelling Biological Pathway Implicated in Numerous Solid Tumor Indications SEATTLE, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on develop
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viadeo
Sign Up For FreeTo access detailed company insights
Viadeo is a professional networking platform that focuses on connecting decision-makers across various industries including retail, media, fintech, IoT, and smart cities. The company offers services related to big data, cloud computing, SEO, and e-health, catering to a diverse clientele that includes publishers and management professionals. Viadeo... Read More
